Skip to main content
FinSpry Logo
FinSpry
VCYT logo
VCYT
(NASDAQ)
Veracyte, Inc.
$42.31-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Veracyte (VCYT) Stock Price & Financial Analysis

Veracyte Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$41.10 - $42.54
52-Week High$60.91
52-Week Low$28.25
Open$42.18
Volume1.01M
Average Volume (3M)1.29M
Market Cap3.47B
Shares Outstanding82.06M
P/E Ratio (TTM)30.16
Forward P/E14.91
Price to Sales (P/S)6.15
Price to Book (P/B)2.57
EV/EBITDA23.95
Revenue (TTM)561.90M
Net Income (TTM)114.48M
Free Cash Flow (TTM)165.46M
EPS (TTM)$1.41
Profit Margin20.37%
Operating Margin19.55%
Return on Equity (ROE)8.52%
Debt to Equity0.03
50-Day MA$52.93
200-Day MA$42.40
52-Week Change39.25%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Veracyte

What is the current stock price for VCYT?

As of the latest trading session, VCYT stock trades at $42.31. The 52-week range is $28.25–$60.91, with a day range of $41.10–$42.54.

What is the P/E ratio for VCYT?

Veracyte's trailing P/E ratio is 30.2, meaning investors pay $30.2 for every $1 of annual earnings. The forward P/E is 14.9, reflecting analyst expectations for future earnings. Veracyte operates in the Healthcare sector.

Does VCYT pay dividends?

Veracyte does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for VCYT?

Based on 6 analysts, the consensus for VCYT is Buy.

What is the market cap of VCYT?

Veracyte's market capitalization is $3.47B, classifying it as a mid-cap company. Veracyte operates in the Healthcare sector within the Diagnostics & Research industry.